Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Project CBD

FEBRUARY 28, 2023

CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing.

CBD 144

CBD Seed-To-Sale Food Access 144

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. million dollar grant from the National Institute on Drug Abuse in 2017 to conduct a 5-year study on the effects of cannabis on HIV.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

NOVEMBER 29, 2019

When a person uses a THC oil pen ( vapingdaily gives more details) to ingest this cannabinoid, it can benefit them in different ways. They make endocannabinoids, and because they have CB1 and CB2 receptors in the body, they use them when they consume cannabinoids like THC. However, cannabinoids use modulation. THC Oil Benefits.

Oil 80

Oil THC Cannabinoids Research and Development 80

LifeCannMD

AUGUST 2, 2024

Certain cannabinoids in marijuana, such as CBD, have anti-inflammatory properties. Cannabinoids like THC and CBD bind to ECS receptors, potentially reducing inflammation and pain perception. More clinical trials are needed to establish definitive efficacy and safety profiles. Migraines are often linked with inflammation.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

Canna Care Docs

DECEMBER 11, 2018

It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. O’Neill, Stephanie.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. medical cannabis users at risk of unfair prosecution, according to a report by Volteface.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

Cannabis Info

OCTOBER 11, 2019

One such breakthrough in research came back in 2017, when researchers found strong evidence that cannabis could help treat dementia. Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. But in recent years, new research both in the U.S.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

The Cannigma

MARCH 15, 2021

DoobTool was created in Halifax, Nova Scotia in 2017, with the “active cannabis consumer in mind” and the goal of “breaking through the stoner stereotypes,” according to the company website. Will the DoobTool make you feel like a survivalist? “The The Hydrology9 NX: A water vape? Is it a bong? Is it a vaporizer? sorta both?

Concentrates 143

Concentrates Clinical Trials Chronic Pain Pets 143

Healer

MARCH 26, 2021

THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant. Seventeen of 19 pre-clinical studies provided “robust” evidence of the opioid-sparing effects of cannabinoids, but one of the nine clinical studies provided “very low-quality” evidence of such, according to the review.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 98

CBD THC Conditions Medicine 98

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

The Joint Blog

FEBRUARY 18, 2020

According to NORML, they reported that the use of medical cannabis, and in particular products dominant in the cannabinoid CBN (cannabinol), was associated with medication-sparing effects. The study is titled Cannabinoid and terpenoid doses are associated with adult ADHD status of medical cannabis patients.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

JUNE 10, 2021

We analyzed annual administrations of TSCI from 2013–2017, which asked respondents about various dimensions of traffic safety, including driving after marijuana use [ 28 ]. Between 2013 and 2017, approximately 3000 TSCI surveys were completed annually. 2017 Traffic Safety Culture Index: AAA Foundation for Traffic Safety; 2018.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

AUGUST 26, 2019

The review found that marijuana, or products having cannabinoids are effective at relieving chronic pain. The comprehensive review of the evidence, published in the journal of Clinical Psychology Review , exposed that using marijuana helps people with alcohol or opioid dependencies to fight against their addictions.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. World Drug Report ‘s estimation that 18 million people between 15 and 64 years of age consumed cocaine in 2017. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

United Patients Group

JANUARY 5, 2023

A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. He adds that research has shown that probiotics can help the immune system produce more antibodies to fight off viruses and bacteria. Probiotics May Reduce Flu Risk.

Digestion 105

Digestion Research and Development Food Strains 105

Freedom Leaf

JULY 20, 2017

Several other observational trials have similarly reported that those with a cannabis use history possess lower BMI , and are less likely to be obese or suffer from adult onset diabetes as compared to non-users.

Blood Pressure 43

Blood Pressure Research and Development Clinical Trials History 43

Alchimia

FEBRUARY 1, 2022

CBD is one of the principal cannabinoids found in cannabis and, along with THC, one of its best-known compounds. The fact that this cannabinoid does not produce the psychoactive effect that we associate with cannabis does not mean that it is an innocuous substance , these concepts are often confused. Does CBD have any side effects?

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

SEPTEMBER 1, 2019

I actually produce more natural cannabinoids than the average person – that’s helped me recover from seven strokes,” says Elisabetta Faenza, now CEO of Australian medicinal cannabis company LeafCann. The clinical trials and the standard of production could lead the world.”. But not everyone agrees. “I

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring. Can medical cannabis be the solution?

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Weedistry

MARCH 11, 2019

There are studies, she said, showing that for pain relief, CBD works best within the plant’s cannabinoid system, meaning that combinations of compounds are more effective than isolated ones. There is a lot less CBD and other cannabinoids in hemp than in cannabis strains that contain THC. von Pfetten said. von Pfetten said.

Oil 40

Oil CBD Wellness and Beauty Clinical Trials 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. It is now deemed an agricultural commodity, no longer able to be classified as a controlled substance, like marijuana.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

SEPTEMBER 3, 2019

(TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. MediPharm Labs Australia was established in 2017.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

NOVEMBER 24, 2021

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). 2019 ), and six US states have permitted post-traumatic stress disorder as a treatable condition by medicinal cannabis (Bridgeman and Abazia 2017 ). 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. A pain management specialist recommended a trial of Nabilone, the synthetic cannabinoid, or of medical marijuana. I decline to award a sum of money to permit the plaintiff to experiment with cannabinoids; … 23.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. and those are intertwined in – they do want THC, but not just THC.

Legalization 128

Legalization Patients Education Dispensary 128

Veriheal

SEPTEMBER 6, 2022

Recent research has found that terpene and cannabinoid profiles are far more significant when trying to produce specific effects. Recent research has found that certain cannabinoids may help with sleep. Terpene and cannabinoid profiles of the cannabis you are consuming will also impact the effects experienced.

Sleep 110

Sleep THC CBD Chronic Pain 110

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

MAY 29, 2022

In 2017, FDA granted a request for Breakthrough Therapy designation for MDMA to treat PTSD. As previously mentioned, clinical studies are promising, including a Phase 3 trial (the last step before submitting an NDA) completed last November. [9] Clinical Trials and Human Subject Protections. 811(b)–(c). [18]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

APRIL 17, 2020

For example, the US government conducted studies and found that dogs have many cannabinoid receptors in their cerebellum, brain stem, and medulla oblongata. — Teddy McDermott (@MayorTomCanine) December 14, 2017. — Teddy McDermott (@MayorTomCanine) December 27, 2017. What’s going on here in Indiana?

Pets 73

Pets Hemp CBD Food 73